Share this
remote microsampling: one breakthrough, many applications
by Neoteryx Microsampling on May 10, 2019 5:10:00 AM
The wonderful thing about being in the biotech and healthcare industries right now is that we have the ability to leverage untold volumes of data and information. There is a lot of innovation happening in biotech and med-tech — we hear about new breakthroughs every day. One such breakthrough is remote microsampling technology, which makes it possible to collect enormous amounts of data from tiny amounts of biological fluid. Thanks to portable Mitra® devices based on Volumetric Absorptive Microsampling technology, it is now possible for nearly anyone to collect a tiny sample of biological fluid, such as capillary blood, as a volumetrically accurate specimen.The applications for the patented VAMS® technology in smarter healthcare are myriad, and only beginning to be properly explored. Here are five of the big ones.
The Application of Blood Microsampling In:
Therapeutic Drug Monitoring
Remote and at-home sampling, facilitated by capillary blood microsampling technology, dramatically simplifies the lives of patients, such as the recipients of organ transplants, who find themselves on strict drug regimens. Before remote sampling, transplant patients had to make frequent trips to the hospital or clinic for blood draws and lab testing as part of therapeutic drug monitoring, or TDM. By self-collecting their own samples and mailing them in, they can eliminate many trips to the hospital or lab.
Patient-centered Care
To practice patient-centered medicine is to make the best of our abundant resources in addressing patients as individuals with specific needs. Once a lab receives a microsample, researchers can analyze the specimen for unique disease biomarkers that provide specific information--helpful for determining which medications or other interventions might work best in clinical practice. Microsampling provides an essential missing link between research and precision medicine, patient monitoring, telemedicine, and telehealth.
Drug Development.
Remote specimen microsampling improves every aspect of clinical trials, from recruitment to retention to adherence and compliance. It opens the door for the location-agnostic, virtual clinical trials of tomorrow. Remote sampling decentralizes clinical trials, allowing study participants in distant locations to mail in their specimen samples and follow up with the trial coordinators via telehealth communications. This convenience encourages better program commitment and adherence among participants, saving hassle in the short run and saving money in the long run.
Preclinical Experimental Animal Testing
Using a small lancet to prick the tail of a small study animal to collect a smaller volume of blood for analysis has been a big breakthrough in preclinical research and testing. This is a less invasive approach that is relatively painless and requires only a small-volume sample. These factors reduce stress on the animal, and allow for sampling from the same animal multiple times with minimal harm. Microsampling and rat tail vein blood collection provide a scientific, financial, and ethical advantage in the preclinical lab, reducing reliance on satellite populations, reducing overall rodent use by up to sevenfold, and reducing stress on animals and their human colleagues alike.
Pediatrics
The improved patient experience associated with blood microsampling using Mitra® devices and a finger-stick collection approach, can spare discomfort or trauma and provide a greater sense of agency for any patient. This approach is less anxiety provoking than getting a blood draw from a vein in the arm. The finger-stick approach is an especially significant improvement when it comes to the care of our smallest and most vulnerable patients, our children.
That's why microsampling in children's hospitals and other pediatric medical contexts in the United Kingdom and Europe is already catching on. At least one program in the UK sends collection kits out to pediatric patients at home, where their parents can perform the sample collection in familiar surroundings, and mail the samples back to the care team for testing.
And it's not just for blood. The same technology that collects small, volumetrically accurate samples of blood is also proving effective in the collection of other biological fluids, including urine, saliva, tears, and more. Opening the door to advances in many areas of research and healthcare.
Share this
- Microsampling (206)
- Research, Remote Research (119)
- Venipuncture Alternative (106)
- Clinical Trials, Clinical Research (83)
- Mitra® Device (73)
- Therapeutic Drug Monitoring, TDM (50)
- Dried Blood Spot, DBS (38)
- Biomonitoring, Health, Wellness (31)
- Infectious Disease, Vaccines, COVID-19 (24)
- Decentralized Clinical Trial (DCT) (22)
- Blood Microsampling, Serology (21)
- Omics, Multi-Omics (19)
- Specimen Collection (17)
- Toxicology, Doping, Drug/Alcohol Monitoring, PEth (17)
- hemaPEN® Device (13)
- Preclinical Research, Animal Studies (12)
- Harpera® Tool (9)
- Pharmaceuticals, Drug Development (9)
- Skin Microsampling, Microbiopsy (8)
- Industry News, Microsampling News (5)
- Antibodies, MAbs (3)
- Company Press Release, Product Press Release (3)
- Environmental Toxins, Exposures (1)
- October 2024 (1)
- September 2024 (1)
- June 2024 (1)
- May 2024 (1)
- April 2024 (4)
- March 2024 (1)
- February 2024 (2)
- January 2024 (4)
- December 2023 (3)
- November 2023 (3)
- October 2023 (3)
- September 2023 (3)
- July 2023 (3)
- June 2023 (2)
- April 2023 (2)
- March 2023 (2)
- February 2023 (2)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (4)
- October 2019 (2)
- September 2019 (4)
- August 2019 (4)
- July 2019 (3)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (5)
- January 2019 (8)
- December 2018 (3)
- November 2018 (4)
- October 2018 (7)
- September 2018 (6)
- August 2018 (5)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (4)
- February 2018 (6)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (4)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
Comments (1)